Breast conserving surgery after neoadjuvant therapy for large primary breast cancer (2008)
- Authors:
- USP affiliated authors: PERIA, FERNANDA MARIS - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; TIEZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ejso.2008.01.015
- Subjects: NEOPLASIAS MAMÁRIAS (CIRURGIA); QUIMIOTERAPIA ADJUVANTE
- Language: Inglês
- Imprenta:
- Source:
- Título: Eurpean Journal of Surgical Oncology
- ISSN: 0748-7983
- Volume/Número/Paginação/Ano: v. 34, n. 8, p. 863-867, 2008
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
TIEZZI, Daniel Guimarães et al. Breast conserving surgery after neoadjuvant therapy for large primary breast cancer. Eurpean Journal of Surgical Oncology, v. 34, n. 8, p. 863-867, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejso.2008.01.015. Acesso em: 15 mar. 2026. -
APA
Tiezzi, D. G., Andrade, J. M. de, Marana, H. R. C., Zola, F. E., & Peria, F. M. (2008). Breast conserving surgery after neoadjuvant therapy for large primary breast cancer. Eurpean Journal of Surgical Oncology, 34( 8), 863-867. doi:10.1016/j.ejso.2008.01.015 -
NLM
Tiezzi DG, Andrade JM de, Marana HRC, Zola FE, Peria FM. Breast conserving surgery after neoadjuvant therapy for large primary breast cancer [Internet]. Eurpean Journal of Surgical Oncology. 2008 ; 34( 8): 863-867.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1016/j.ejso.2008.01.015 -
Vancouver
Tiezzi DG, Andrade JM de, Marana HRC, Zola FE, Peria FM. Breast conserving surgery after neoadjuvant therapy for large primary breast cancer [Internet]. Eurpean Journal of Surgical Oncology. 2008 ; 34( 8): 863-867.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1016/j.ejso.2008.01.015 - Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- Trastuzumab-induced myocardiotoxicity mimicking acute coronary syndrome
- Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer
- Genetic profile analysis of tumor stem cells in locally advanced breast cancer
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
